Cargando…
A novel nomogram to predict survival of patients with hepatocellular carcinoma after transarterial chemoembolization: a tool for retreatment decision making
BACKGROUND: There is still no standardized policy regarding how to identify patients who are not benefiting from transarterial chemoembolization (TACE). We aimed to establish and validate a nomogram model to predict the survival rate of hepatocellular carcinoma (HCC) patients after TACE. METHODS: A...
Autores principales: | Li, Jie, Li, Chengjun, Zhu, Guoqing, Yang, Junhui, Zhang, Yunjie, Yu, Zhijie, Xia, Jinglin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929754/ https://www.ncbi.nlm.nih.gov/pubmed/36819596 http://dx.doi.org/10.21037/atm-22-6513 |
Ejemplares similares
-
A Nomogram Based on Preoperative Lipiodol Deposition after Sequential Retreatment with Transarterial Chemoembolization to Predict Prognoses for Intermediate-Stage Hepatocellular Carcinoma
por: Niu, Xiang-Ke, et al.
Publicado: (2022) -
Tumor Response and Nomogram-Based Prognostic Stratification for Hepatocellular Carcinoma After Drug-Eluting Beads Transarterial Chemoembolization
por: Ji, Kun, et al.
Publicado: (2022) -
Novel Prognostic Nomogram to Predict Progression-Free Survival of Patients with Hepatocellular Carcinoma After Transarterial Chemoembolization
por: Xi, Dong, et al.
Publicado: (2023) -
Decision-Making Scoring System for the Repetition of Conventional Transarterial Chemoembolization in Patients With Inoperable Hepatocellular Carcinoma
por: Bannangkoon, Kittipitch, et al.
Publicado: (2022) -
Nomogram for predicting pathologic complete response after transarterial chemoembolization in patients with hepatocellular carcinoma
por: Lin, Jian, et al.
Publicado: (2021)